id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-N-1429-0020,FDA,FDA-2013-N-1429,"Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Registration of Human Drug Compounding Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act and Associated Fees",Notice,30 Day Proposed Information Collection,2020-11-18T05:00:00Z,2020,11,2020-11-18T05:00:00Z,2020-12-19T04:59:59Z,2023-07-20T14:23:39Z,2020-25411,0,0,0900006484966148
FDA-2013-N-1429-0019,FDA,FDA-2013-N-1429,"Agency Information Collection Activities; Proposed Collection; Comment Request; Registration of Human Drug Compounding Outsourcing Facilities under Section 503B of the Federal Food, Drug, and Cosmetic Act and Associated Fees",Notice,60 Day Proposed Information Collection,2020-08-20T04:00:00Z,2020,8,2020-08-20T04:00:00Z,2020-10-20T03:59:59Z,2023-07-20T14:23:14Z,2020-18254,0,0,0900006484813fd6